Bladder cancer is one of the most frequent cancers and causes more than 150.000 deaths each year. During the last decade, several studies provided important aspects about genomic characterization, consensus subgroup definition, and transcriptional regulation of bladder cancer. Still, much more research needs to be done to characterize molecular signatures of this cancer in depth. At this point, the use of bladder cancer cell lines is quite useful for the identification and test of new signatures. In this study, we classified the bladder cancer cell lines according to the activities of regulons implicated in the regulation of primary bladder tumors. Our regulon gene expression-based classification revealed three groups, neuronal-basal (NB), ...
Despite advances in management, bladder cancer remains a major cause of cancer related complications...
The rapid development of the cancer stem cells (CSC) field, together with powerful genome-wide scree...
The rapid development of the cancer stem cells (CSC) field, together with powerful genome-wide scree...
A human bladder cancer model of nine cell sublines derived from the BL17/2 cell line was used to eva...
INTRODUCTION: We previously identified common differentially expressed (DE) genes in bladder cancer ...
In the age of personalized medicine stratifying tumors into molecularly defined subtypes associated ...
Background. Urothelial bladder cancer is a highly heterogeneous disease. Cancer cell lines are usefu...
A variety of genetic alterations and gene expression changes are involved in the pathogenesis of bla...
AbstractA variety of genetic alterations and gene expression changes are involved in the pathogenesi...
Transitional cell carcinoma of the bladder is a common tumor. While most patients presenting superfi...
Approximately 50% of patients with muscle-invasive bladder cancer (MIBC) develop metastatic disease,...
Current diagnosis and treatment of urinary bladder cancer (BC) has shown great progress with the uti...
Urothelial carcinoma of the bladder is the most frequent bladder cancer affecting more than 400,000 ...
Background: It has been suggested that bladder cancer can be divided into two molecular subtypes ref...
Tumor recurrence is a major clinical concern for patients with urothelial carcinoma of the urinary b...
Despite advances in management, bladder cancer remains a major cause of cancer related complications...
The rapid development of the cancer stem cells (CSC) field, together with powerful genome-wide scree...
The rapid development of the cancer stem cells (CSC) field, together with powerful genome-wide scree...
A human bladder cancer model of nine cell sublines derived from the BL17/2 cell line was used to eva...
INTRODUCTION: We previously identified common differentially expressed (DE) genes in bladder cancer ...
In the age of personalized medicine stratifying tumors into molecularly defined subtypes associated ...
Background. Urothelial bladder cancer is a highly heterogeneous disease. Cancer cell lines are usefu...
A variety of genetic alterations and gene expression changes are involved in the pathogenesis of bla...
AbstractA variety of genetic alterations and gene expression changes are involved in the pathogenesi...
Transitional cell carcinoma of the bladder is a common tumor. While most patients presenting superfi...
Approximately 50% of patients with muscle-invasive bladder cancer (MIBC) develop metastatic disease,...
Current diagnosis and treatment of urinary bladder cancer (BC) has shown great progress with the uti...
Urothelial carcinoma of the bladder is the most frequent bladder cancer affecting more than 400,000 ...
Background: It has been suggested that bladder cancer can be divided into two molecular subtypes ref...
Tumor recurrence is a major clinical concern for patients with urothelial carcinoma of the urinary b...
Despite advances in management, bladder cancer remains a major cause of cancer related complications...
The rapid development of the cancer stem cells (CSC) field, together with powerful genome-wide scree...
The rapid development of the cancer stem cells (CSC) field, together with powerful genome-wide scree...